Influence of Chronic Nicotine Administration on Cerebral Type 1 Cannabinoid Receptor Binding: An In Vivo Micro-PET Study in the Rat Using [18F]MK-9470

2010 ◽  
Vol 42 (2) ◽  
pp. 162-167 ◽  
Author(s):  
Nathalie Gérard ◽  
Jenny Ceccarini ◽  
Guy Bormans ◽  
Bert Vanbilloen ◽  
Cindy Casteels ◽  
...  
Keyword(s):  
Receptor Binding ◽  
Cannabinoid Receptor ◽  
Chronic Nicotine ◽  
Nicotine Administration ◽  
Type 1 Cannabinoid Receptor

An in vivo [18F]MK-9470 microPET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam

2008 ◽  
Vol 54 (7) ◽  
pp. 1103-1106 ◽  
Author(s):  
Karolien Goffin ◽  
Guy Bormans ◽  
Cindy Casteels ◽  
Barbara Bosier ◽  
Didier M. Lambert ◽  
...  
Keyword(s):  
Receptor Binding ◽  
Wistar Rats ◽  
Cannabinoid Receptor ◽  
Chronic Administration ◽  
Type 1 Cannabinoid Receptor

scholarly journals Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice

2014 ◽  
Vol 35 (12) ◽  
pp. 2858-2869 ◽  
Author(s):  
Maarten Ooms ◽  
Roma Rietjens ◽  
Janaki Raman Rangarajan ◽  
Kathleen Vunckx ◽  
Sara Valdeolivas ◽  
...  
Keyword(s):  
Receptor Binding ◽  
Cannabinoid Receptor ◽  
Phosphodiesterase 10A ◽  
Type 1 Cannabinoid Receptor

scholarly journals Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo

2010 ◽  
Vol 51 (9) ◽  
pp. 1413-1417 ◽  
Author(s):  
K. Van Laere ◽  
C. Casteels ◽  
I. Dhollander ◽  
K. Goffin ◽  
I. Grachev ◽  
...  
Keyword(s):  
Huntington Disease ◽  
Cannabinoid Receptor ◽  
Type 1 Cannabinoid Receptor

IN VIVO PET IMAGING OF CEREBRAL TYPE 1 CANNABINOID RECEPTOR AVAILABILITY IN PATIENTS WITH SCHIZOPHRENIA

2010 ◽  
Vol 117 (2-3) ◽  
pp. 170 ◽  
Author(s):  
Jenny Ceccarini ◽  
Marc De Hert ◽  
Ruud van Winkel ◽  
Dagmar Koethe ◽  
Guy Bormans ◽  
...  
Keyword(s):  
Pet Imaging ◽  
Cannabinoid Receptor ◽  
Type 1 Cannabinoid Receptor

scholarly journals Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo

2012 ◽  
Vol 33 (3) ◽  
pp. 620.e1-620.e8 ◽  
Author(s):  
Koen Van Laere ◽  
Cindy Casteels ◽  
Sophie Lunskens ◽  
Karolien Goffin ◽  
Igor D. Grachev ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Cannabinoid Receptor ◽  
Type 1 Cannabinoid Receptor

scholarly journals In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease

2010 ◽  
Vol 1316 ◽  
pp. 153-162 ◽  
Author(s):  
Cindy Casteels ◽  
Erwin Lauwers ◽  
Abdelbari Baitar ◽  
Guy Bormans ◽  
Veerle Baekelandt ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Rat Model ◽  
Cannabinoid Receptor ◽  
Receptor Mapping ◽  
6 Hydroxydopamine ◽  
Type 1 Cannabinoid Receptor

Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding

Synapse ◽  
2010 ◽  
Vol 64 (8) ◽  
pp. 617-623 ◽  
Author(s):  
Cindy Casteels ◽  
Bert Vanbilloen ◽  
Dorien Vercammen ◽  
Barbara Bosier ◽  
Didier M. Lambert ◽  
...  
Keyword(s):  
Receptor Binding ◽  
Cannabinoid Receptor ◽  
Type 1 Cannabinoid Receptor

Interictal Type 1 Cannabinoid Receptor Binding is Increased in Female Migraine Patients

2011 ◽  
Vol 52 (3) ◽  
pp. 433-440 ◽  
Author(s):  
Bart J. Van der Schueren ◽  
Koen Van Laere ◽  
Nathalie Gérard ◽  
Guy Bormans ◽  
Jan N. De Hoon
Keyword(s):  
Receptor Binding ◽  
Cannabinoid Receptor ◽  
Type 1 Cannabinoid Receptor

In vivo type 1 cannabinoid receptor availability in Alzheimer's disease

2014 ◽  
Vol 24 (2) ◽  
pp. 242-250 ◽  
Author(s):  
Rawaha Ahmad ◽  
Karolien Goffin ◽  
Jan Van den Stock ◽  
François-Laurent De Winter ◽  
Evy Cleeren ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cannabinoid Receptor ◽  
Type 1 Cannabinoid Receptor
Sign in / Sign up

Export Citation Format

Share Document